Evolution of treatment regimens in multiple myeloma: a social network analysis.
<h4>Background</h4>Randomized controlled trials (RCTs) are considered the gold standard for assessing the efficacy of new treatments compared to standard treatments. However, the reasoning behind treatment selection in RCTs is often unclear. Here, we focus on a cohort of RCTs in multiple...
Guardado en:
Autores principales: | Helen Mahony, Athanasios Tsalatsanis, Ambuj Kumar, Benjamin Djulbegovic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/826ce55a8e96412699a28b0f1c65a588 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evolution and structure of clinically relevant gene fusions in multiple myeloma
por: Steven M. Foltz, et al.
Publicado: (2020) -
The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Georgia Stewart, et al.
Publicado: (2021) -
Multiple myeloma
por: Larisa P. Mendeleeva, et al.
Publicado: (2021) -
Co-evolution of tumor and immune cells during progression of multiple myeloma
por: Ruiyang Liu, et al.
Publicado: (2021) -
Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma
por: Fatih M. Uckun, et al.
Publicado: (2021)